HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

• Marica Garziera ,

  * E-mail: mgarziera@cro.it

  Affiliation Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Ettore Bidoli,

  Affiliation Epidemiology and Biostatistic Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Erika Cecchin,

  Affiliation Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Enrico Mini,

  Affiliation Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  ⨯
• Stefania Nobili,

  Affiliation Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy

  ⨯
• Sara Lonardi,

  Affiliation Medical Oncology Unit 1, Istituto Oncologico Veneto-IRCCS, Padua, Italy

  ⨯
• Angela Buonadonna,

  Affiliation Division of Medical Oncology B; Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Domenico Errante,

  Affiliation Medical Oncology Unit, Ospedale Civile di Vittorio Veneto, Vittorio Veneto (TV), Italy

  ⨯
• Nicoletta Pella,

  Affiliation Medical Oncology Unit, University Hospital, Piazza S. Maria Della Misericordia, Udine, Italy

  ⨯
• Mario D’Andrea,

  Affiliation Medical Oncology Unit, “San Filippo Neri Hospital”, Piazza Di S. Maria Della Pietà, Rome, Italy

  ⨯
• Francesco De Marchi,

  Affiliation Surgical Oncology Department, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Antonino De Paoli,

  Affiliation Radiotherapy Department, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Chiara Zanusso,

  Affiliation Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Elena De Mattia,

  Affiliation Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• Renato Tassi,

  Affiliation Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  ⨯
•  [ ... ],
• Giuseppe Toffoli

  Affiliation Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano National Cancer Institute, via F. Gallini 2, 33081 Aviano, Italy

  ⨯
• [ view all ]
• [ view less ]